Relaxin stimulates expression of vascular endothelial growth factor in normal human endometrial cells in vitro and is associated with menometrorrhagia in women

Human Reproduction

Volumn 14, Issue 3, 1999, Pages 800-806

  Unemori, Elaine N ^a   Erikson, Mark E ^a   Rocco, Susan E ^a   Sutherland, Kerri M ^a   Parsell, Dawn A ^a   Mak, John ^a   Grove, Beverly H ^a  

^a Bradley Pharmaceuticals Inc   (United States)

Author keywords

Endometrium; Menometrorrhagia; Menstrual cycle; Relaxin; Vascular endothelial growth factor

Indexed keywords

CYCLIC AMP; RELAXIN; VASCULOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS LUTEUM; DOUBLE BLIND PROCEDURE; ENDOMETRIUM CELL; FEMALE; HORMONE RELEASE; HUMAN; HUMAN CELL; MENSTRUATION; METRORRHAGIA; NEOVASCULARIZATION (PATHOLOGY); RANDOMIZED CONTROLLED TRIAL; SECOND MESSENGER; SUBCUTANEOUS DRUG ADMINISTRATION;

RODENTIA;

EID: 0033037935     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.3.800     Document Type: Article

References (35)

1. Brennand, J.E., Calder, A.A., Leitch, C.R. et al. (1997) Recombinant human relaxin as a cervical ripening agent. Br. J. Obstet. Gynaecol., 10-4, 775-780.
2. Bryant-Greenwood, G.D., Rutanen, E.-M., Partanen, S. étal (1993) Sequential appearance of relaxin, prolactin and IGFBP-1 during growth and differentiation of the human endometrium. Mol. Cell. Endocrinol. 95,23-19.
3. Chamock-Jones, D.S., Sharkey, A.M., Rajput-Williams et al. (1993) Identification and localization of alternatively spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol. Reprod., 48, 1120-1128.
4. Cheah, S.H., Ng, K.H., Johgalingam, V.T. etal. (1995) The effects of oestradiol and relaxin on extensibility and collagen organisation of the pregnant rat cervix. J. Endocrinol., 146, 331-337.
5. Claffey, K.P., Wilkison, W.O. and Spiegelman, B.M. (1992) Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J. Biol. Chem., 267, 16 317-16 322.
6. Cullinan-Bove, K. and Koos, R.D. (1993) Vascular endothelial growth factor/vascular permeability factor in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology, 133, 829-837.
7. Dallenbach-Helhveg, G., Dawson, A.B. and Hisaw, F.L. (1966) The effect of relaxin on the endometrium of monkeys. Histological and histochemical studies. Am. J. Anat., 119, 61-78.
8. Das, S.K., Chakraborty, I., Wang, J. et al. (1997) Expression of vascular endothelial growth factor (VEGF) and VEGF-receptor messenger ribonucleic acids in the peri-implantation rabbit uterus. Biol. Reprod., 56, 1390-1399.
9. Fei, D.T.W., Gross, M.C., Lofgren, J.L. et al (1990) Cyclic AMP response to recombinant human relaxin by cultured human endometrial cells - a specific and high throughput in vitro bioassay. Biochem. Biophys. Res. Comm., 170, 214-222.
10. Ferrara, N., Chen, H., Davis-Smyth, T. et al. (1998) Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nature Med., 4, 336-340.
11. Ferrara, N. and Davis-Smyth T. (1997) The biology of vascular endothelial growth factor. Endocrine Rev., 18, 4-25.
12. Goldsmith, L.T., Weiss, G. and Steinetz, E.G. (1995) Relaxin and its role in pregnancy. Endocrinol. Metab. Clin. North Am., 24, 171-186.
13. Huang, J.R., Bellino, F.L., Osawa, Y. and Tseng, L. (1989) Immunologie identification of the aromatase enzyme system in human endometrium. J. Steroid Biochem., 33, 1043-1047.
14. Hisaw, F.L., Hisaw, F.L.Jr, and Dawson, A.B. (1967) Effects of relaxin on the endothelial of endometrial blood vessels in monkeys. Endocrinol., 81, 375-385.
15. Hudson, P., John, M., Crawford, R. et al. (1984) Relaxin gene expression in human ovaries and the predicted structure of a human preprorelaxin by analysis of cDNA clones. EMBO J., 3, 2333-2339.
16. Hurley, W.L., Doane, R.M., O'Day-Bowman, M.B. et al. (1991) Effect of relaxin on mammary development in ovariectomized pregnant gilts. Endocrinology, 128, 1285-1290.
17. Jauniaux, E., Johnson, M.R., Jurkovic, D. et al. (1994) The role of relaxin in the development of the uteroplacental circulation in early pregnancy. Obstet. Gynecol, 84, 338-342.
18. Kuenzi, M.J., Connolly, B.A. and Sherwood, O.D. (1995) Relaxin acts directly on rat mammary nipples to stimulate their growth. Endocrinology, 136, 2943-2947.
19. Lee, A., Christensen, L.K., Stouffer, R.L. et al. (1997) Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization. Ferlil. Steril., 68, 305-311.
20. Munson, P.J. and Rodbard, D. (1980) Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem., 107, 220-239.
21. Osheroff, P.L. and King, K.L. (1995) Binding and cross-linking of 32P-labeled human relaxin to human uterine cells and primary rat atrial cardiomyocytes. Endocrinology, 136, 4377-4381.
22. Osheroff, P.L., Ling, V.T., Vandlen, R.L. et al. (1990) Preparation of biologically active 32P-labeled human relaxin. Displaceable binding to rat uterus, cervix, and brain. J. Biol. Chem., 265, 9396-9401.
23. Parsell, D.A., Mak, J.Y., Amento, E.P. et al. (1996) Relaxin binds to and elicits a response from cells of the human monocytic cell line, THP-1. J. Biol. Chem., 271, 27 936-27 941.
24. Petersen, L.K., Svane, D., Uldbjerg, N. et al. (1991) Effects of human relaxin on isolated rat and human myometrium and uteroplacental arteries. Obstet. Gynecol., 78, 757-762.
25. Shweiki, D., Itin, A., Neufeld, G. et al. (1993) Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J. Clin. Invest., 91, 2235-2243.
26. Seibold, J.R., Kom, J., Simms, R. et al. (1997) Controlled trial of recombinant human relaxin (rhRlxn) in diffuse scleroderma (DS). Arthritis Rheum., 40, S123.
27. Sherwood, O.D. (1994). Relaxin. In Knobil, E.A. and Neill, J.D. (eds), Tlie Physiology of Reproduction. Raven Press Ltd, New York, pp. 861-1009.
28. Shifren, J.L., Tseng, J.F., Zaloudek, C.J. et al. (1996) Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J. Clin. Endocrinol. Metab., 81, 3112-3118.
29. Stewart, D.R., Celniker, A.C., Taylor, C.A. et al. (1990) Relaxin in the periimplantation period. J. Clin. Endocrinol. Metab., 70, 1771-1773.
30. Stewart, D.R., Erikson, M.S., Erikson, M.E. et al. (1997) The role of relaxin in glycodelin secretion. J. Clin. Endocrin. Metab., 82, 839-846.
31. Tischer, E., Mitchell, R., Hartman, T. et al. (1991) The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem., 266, 11 947-11 954.
32. Tony, D.S. and Tony, R.J. (1997) Angiogenesis and the expression of vascular endothelial growth factor in endometrium and placenta. Am. J. Reprod. ImmimoL, 37, 21-29.
33. Tseng, L., Gao, J.-G., Chen, R. et al. ( 1992) Effect of progestin, anti-progestin, and relaxin on the accumulation of prolactin and insulin-like growth factorbinding protein-1 messenger ribonucleic acid in human endometrial stromal cells. Biol. Reprod., 47, 441-450.
34. Unemori, E.N., Pickford, L.B., Salles, A.L. et al. (1996) Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts m vitro and inhibits lung fibrosis in a murine model m vivo. J. Clin. Invest., 98, 2739-2745.
35. Yki-Jarvinen, H., Wahlstrom, T. and Seppala, M. (1985) Human endometrium contains relaxin that is progesterone-dependent. Acta Obstet. Gynecol. Scand., 64, 663-665.